Article info
PDFOriginal article
Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent
- Correspondence to Dr Emma Niméus, Department of Clinical Sciences Lund, Oncology and Pathology, Medicon Village, By 406, Lund SE-223 81, Sweden; Emma.Nimeus{at}med.lu.se
Citation
Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent
Publication history
- Received April 21, 2015
- Revised June 16, 2015
- Accepted June 22, 2015
- First published July 14, 2015.
Online issue publication
June 14, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/